Vivos (RDGL) Share-based Compensation Growth (1y) (2011 - 2025)
Vivos (RDGL) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 7.56% |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 16.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.16% |
| Sep 30, 2025 | -80.97% |
| Jun 30, 2025 | 24.99% |
| Mar 31, 2025 | -50.56% |
| Dec 31, 2022 | 378.36% |
| Mar 31, 2018 | -98.41% |
| Sep 30, 2017 | -11.46% |
| Jun 30, 2017 | -95.37% |
| Mar 31, 2015 | 161.47% |
| Dec 31, 2014 | 373.77% |
| Sep 30, 2014 | -16.92% |
| Mar 31, 2014 | 39.74% |
| Dec 31, 2013 | -77.27% |
| Sep 30, 2013 | -99.17% |
| Jun 30, 2013 | 46.08% |
| Mar 31, 2013 | -97.83% |
| Dec 31, 2012 | 327.66% |
| Mar 31, 2012 | 1,895.24% |
| Dec 31, 2011 | -31.13% |